Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

An Effectiveness-Implementation Trial of SPIRIT in ESRD

ClinicalTrials.gov ID: NCT03138564

Public ClinicalTrials.gov record NCT03138564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 10:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Despite advances in dialysis, only 50% of dialysis patients are alive 3 years after the onset of end-stage renal disease (ESRD). Although withdrawal of dialysis precedes 1 in 4 deaths of patients with ESRD, withdrawal from dialysis and aggressive treatment is rarely discussed by patients and their surrogates with sufficient time to consider alternatives such as hospice or dying at home. Over the last decade, the researchers have developed and iteratively tested a patient and family-centered advance care planning intervention based on the Representational Approach to Patient Education called "Sharing Patient's Illness Representation to Increase Trust" (SPIRIT). SPIRIT is a 6-step, 2-session, face-to-face intervention to promote cognitive and emotional preparation for end-of-life decision making for patients with ESRD and their surrogates. This study is a multicenter, clinic-level cluster randomized trial to evaluate the effectiveness of SPIRIT delivered by dialysis care providers as part of routine care in free-standing outpatient dialysis clinics compared to usual care plus delayed SPIRIT implementation. The researchers will recruit 400 dyads of patients at high risk of death in the next year and their surrogates from dialysis clinics in four states. Patients and surrogates will complete questionnaires at baseline and two weeks after the intervention. Surrogates will complete a post-bereavement assessment three months after the death of the patient.

Study identification

NCT ID
NCT03138564
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Emory University
Other
Enrollment
852 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 15, 2018 (Actual)
Primary completion
Mar 24, 2022 (Actual)
Completion
Nov 21, 2025 (Actual)
Last update posted
May 7, 2026

2018 – 2025

United States locations

U.S. sites
39
U.S. states
5
U.S. cities
32
Facility City State ZIP Site status
Emory Dialysis at Northside Atlanta Georgia 30318 —
Emory Dialysis at Greenbriar Atlanta Georgia 30331 —
Emory Dialysis at Candler Decatur Georgia 30034 —
Emory Dialysis Center North Decatur Georgia 30033 —
Dialysis Clinic, Inc - Acoma Canoncito Laguna Acoma Pueblo New Mexico 87034 —
Dialysis Clinic, Inc - Albuquerque Albuquerque New Mexico 87102 —
Dialysis Clinic, Inc - Albuquerque South Albuquerque New Mexico 87105 —
Dialysis Clinic, Inc - Albuquerque East Albuquerque New Mexico 87110 —
Dialysis Clinic, Inc - Carlsbad Carlsbad New Mexico 88220 —
Dialysis Clinic, Inc - Cuba Cuba New Mexico 87013 —
Dialysis Clinic, Inc - Grants Grants New Mexico 87020 —
Dialysis Clinic, Inc - Raton Raton New Mexico 87740 —
Dialysis Clinic, Inc - Rio Rancho Rio Rancho New Mexico 87124 —
Dialysis Clinic, Inc - Santo Domingo Santo Domingo Pueblo New Mexico 87052 —
Dialysis Clinic, Inc - Silver City Silver City New Mexico 88061 —
Dialysis Clinic, Inc - Taos Taos New Mexico 87571 —
Carolina Dialysis - Carrboro Carrboro North Carolina 27510 —
Carolina Dialysis - Mebane Mebane North Carolina 27302 —
Carolina Dialysis - Pittsboro Pittsboro North Carolina 27312 —
Fresenius Kidney Care - Raleigh Raleigh North Carolina 27610 —
Carolina Dialysis-Sanford Lee County Sanford North Carolina 27332 —
Carolina Dialysis-Sanford Main Sanford North Carolina 27332 —
Carolina Dialysis - Siler City Siler City North Carolina 27344 —
Dialysis Clinic, Inc - Harmar Village Cheswick Pennsylvania 15024 —
Dialysis Clinic, Inc - Monroeville/Five Points Monroeville Pennsylvania 15146 —
Dialysis Clinic, Inc - North Versailles North Versailles Pennsylvania 15137 —
Dialysis Clinic, Inc - Oakland Pittsburgh Pennsylvania 15213 —
Dialysis Clinic, Inc - Banksville Pittsburgh Pennsylvania 15216 —
Dialysis Clinic, Inc - Wilkinsburg Pittsburgh Pennsylvania 15221 —
Dialysis Clinic, Inc - North Hills Pittsburgh Pennsylvania 15237 —
UVA Dialysis Altavista Clinic Altavista Virginia 24517 —
UVA Dialysis Amherst Clinic Amherst Virginia 24521 —
Kidney Center Outpatient Dialysis Clinic Charlottesville Virginia 22903 —
UVA Dialysis Clinic Farmville Farmville Virginia 23901 —
UVA Augusta Dialysis Fishersville Virginia 22939 —
UVA Dialysis Zion Crossroads Gordonsville Virginia 22942 —
UVA Dialysis Lynchburg Lynchburg Virginia 24501 —
UVA Dialysis Orange Clinic Orange Virginia 22960 —
UVA Dialysis Clinic Staunton Staunton Virginia 24401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03138564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03138564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →